Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism

被引:45
|
作者
Kato, K [1 ]
Sato, H [1 ]
Takebe, Y [1 ]
机构
[1] Natl Inst Infect Dis, Ctr AIDS Res, Lab Mol Virol & Epidemiol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
D O I
10.1128/JVI.73.7.5520-5526.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To assess the role of naturally occurring basic amino acid substitutions in the V3 loop of human immunodeficiency virus type 1 (HN-I) subtype E on viral coreceptor usage and cell tropism, we have constructed a panel of chimeric viruses with mutant V3 loops of HIV-1 subtype E in the genetic background of HIV-1(LAI). The arginine substitutions naturally occurring at positions 8, 11, and 18 of the V3 loop in an HIV-1 subtype E X4 strain were systematically introduced into that of an R5 strain to generate a series of V3 loop mutant chimera. These chimeric viruses were employed in virus infectivity assays using HOS-CD4 cells expressing either CCR5 or CXCR4, peripheral blood mononuclear cells, T-cell lines, or macrophages. The arginine substitution at position 11 of the V3 loop uniformly caused the loss of infectivity in HOS-CD4-CCR5 cells, indicating that position 11 is critical for utilization of CCR5. CXCR4 usage was conferred by a minimum of two arginine substitutions, regardless of combination, whereas arginine substitutions at position 8 and 11 were required for T-cell line tropism. Nonetheless, macrophage tropism was not conferred by the V3 loop of subtype E R5 strain per se. We found that the specific combinations of amino acid changes in HIV-1 subtype E env V3 loop are critical for determining viral coreceptor usage and cell tropism, However, the ability to infect HOS-CD4 cells through either CXCR5 or CCR5 is not necessarily correlated with T-cell or macrophage tropism, suggesting that cellular tropism is not dictated solely by viral coreceptor utilization.
引用
收藏
页码:5520 / 5526
页数:7
相关论文
共 50 条
  • [31] Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
    Stanfield, RL
    Ghiara, JB
    Saphire, EO
    Profy, AT
    Wilson, IA
    VIROLOGY, 2003, 315 (01) : 159 - 173
  • [32] CONSERVED V3 LOOP SEQUENCES AND TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SHPAER, EG
    DELWART, EL
    KUIKEN, CL
    GOUDSMIT, J
    BACHMANN, MH
    MULLINS, JI
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1679 - 1684
  • [33] The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood
    Endrich, MM
    Gehring, H
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 252 (03): : 441 - 446
  • [34] Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences
    Jensen, MA
    Li, FS
    van't Wout, AB
    Nickle, DC
    Shriner, D
    He, HX
    McLaughlin, S
    Shankarappa, R
    Margolick, JB
    Mullins, JI
    JOURNAL OF VIROLOGY, 2003, 77 (24) : 13376 - 13388
  • [35] COVARIATION OF MUTATIONS IN THE V3 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN - AN INFORMATION-THEORETIC ANALYSIS
    KORBER, BTM
    FARBER, RM
    WOLPERT, DH
    LAPEDES, AS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 7176 - 7180
  • [36] V3 loop of human immunodeficiency virus type 1 suppresses interleukin 2-induced T cell growth
    Sakaida, H
    Murakami, T
    Kawamata, S
    Hattori, T
    Uchiyama, T
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (02) : 151 - 159
  • [37] STUDIES ON THE ROLE OF THE V3-LOOP IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN FUNCTION
    CHOU, SH
    FREED, EO
    PANGANIBAN, AT
    KENEALY, WR
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (09) : 1611 - 1618
  • [38] Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions
    Jackson, NAC
    Levi, M
    Wahren, B
    Dimmock, NJ
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 225 - 236
  • [39] Full-length sequence of human immunodeficiency virus type 1 subtype A, recombined with subtype C in the env V3 domain
    Sherefa, K
    Johansson, B
    Salminen, M
    Sönnerborg, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 289 - 292
  • [40] Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor
    Yamaguchi-Kabata, Y
    Yamashita, M
    Ohkura, S
    Hayami, M
    Miura, T
    JOURNAL OF MOLECULAR EVOLUTION, 2004, 58 (03) : 333 - 340